New research in colorectal cancers directed by investigators at the Johns Hopkins Kimmel Cancer Center suggests that expression of transcription factors — proteins that help turn specific genes on or off by binding to nearby DNA — may play a central role in the degree of DNA methylation across the genome, contributing to the development of different subtypes of these cancers.
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Université de Montréal gains access to ERS Genomics’ CRISPR/Cas9 patents, launching platforms for genome-wide screening and fostering research collaborations.
October 1, 2024